{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:42:25Z","timestamp":1774647745241,"version":"3.50.1"},"reference-count":132,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1053\/j.semdp.2022.06.016","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T23:19:10Z","timestamp":1656544750000},"page":"355-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Update on sentinel node pathology in breast cancer"],"prefix":"10.1053","volume":"39","author":[{"given":"Beth","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2022.06.016_bib0001","article-title":"De-escalating axillary surgery in early-stage breast cancer","author":"Hersh","year":"2021","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2022.06.016_bib0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.semdp.2022.06.016_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0004","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2011.1034","article-title":"Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer","volume":"306","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.semdp.2022.06.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162605","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2022.06.016_bib0008","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1015-9584(09)60048-8","article-title":"Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management","volume":"27","author":"Xing","year":"2004","journal-title":"Asian J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0009","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.semdp.2022.06.016_bib0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0011","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0012","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ajcp\/aqab055","article-title":"How do pathologists in academic institutions across the united states and canada evaluate sentinel lymph nodes in breast cancer? A practice survey","volume":"156","author":"Asirvatham","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0014","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semdp.2022.06.016_bib0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0017","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/annonc\/mdn746","article-title":"Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial","volume":"20","author":"Canavese","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0018","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","article-title":"Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial","volume":"23","author":"Purushotham","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0019","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1015-9584(09)60052-X","article-title":"Australasian experience and trials in sentinel lymph node biopsy: the RACS SNAC trial","volume":"27","author":"Ung","year":"2004","journal-title":"Asian J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","article-title":"A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial","volume":"247","author":"Zavagno","year":"2008","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0021","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.1000","article-title":"10-yr follow-up results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients","volume":"31","author":"Julian","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0022","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0023","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0024","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","article-title":"Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial","volume":"34","author":"Del Bianco","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1053\/j.semdp.2022.06.016_bib0026","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0027","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS18-GS4-01","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981\/22023)","volume":"79","author":"Rutgers","year":"2019","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2022.06.016_bib0028","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: american society of clinical oncology clinical practice guideline update","volume":"35","author":"Lyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0029","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0030","unstructured":"National Comprehensive Cancer Network. Breast cancer (Version 2.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Published 2021. Accessed April 26, 2022."},{"key":"10.1053\/j.semdp.2022.06.016_bib0031","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0959-8049(03)00203-X","article-title":"Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines","volume":"39","author":"Cserni","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0032","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y","article-title":"Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma","volume":"92","author":"Viale","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0033","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00268-001-0009-4","article-title":"Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection","volume":"25","author":"Veronesi","year":"2001","journal-title":"World J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0034","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","article-title":"Improved axillary staging of breast cancer with sentinel lymphadenectomy","volume":"222","author":"Giuliano","year":"1995","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00000658-199709000-00006","article-title":"Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma","volume":"226","author":"Turner","year":"1997","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0036","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.11865","article-title":"Classification of isolated tumor cells: clarification of the 6th edition of the American joint committee on cancer staging manual","volume":"98","author":"Singletary","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0037","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1053\/j.semdp.2022.06.016_bib0038","unstructured":"Fitzgibbons P.L.C., J.L.; With Guidance from CAP Cancer and CAP Pathology Electronic Reporting Committees. Protocol for the Examination of Biopsy Specimens from Patients with Invasive Carcinoma of the Breast (Version 1.1.1.1). In: Pathologists CoA, ed2021."},{"key":"10.1053\/j.semdp.2022.06.016_bib0039","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jnci\/djn343","article-title":"Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node","volume":"100","author":"van Deurzen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semdp.2022.06.016_bib0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ejso.2001.1138","article-title":"Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla","volume":"27","author":"Cserni","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0041","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.surg.2015.03.049","article-title":"Occult metastases in node-negative breast cancer: a surveillance, epidemiology, and end results-based analysis","volume":"158","author":"Kimbrough","year":"2015","journal-title":"Surgery"},{"key":"10.1053\/j.semdp.2022.06.016_bib0042","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer","volume":"361","author":"de Boer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0043","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jnci\/djq008","article-title":"Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases","volume":"102","author":"de Boer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semdp.2022.06.016_bib0044","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.SABCS13-S2-05","volume":"73","author":"Julian","year":"2013","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2022.06.016_bib0045","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1245\/s10434-011-1593-7","article-title":"Multidisciplinary considerations in the implementation of the findings from the American college of surgeons oncology group (ACOSOG) Z0011 study: a practice-changing trial","volume":"18","author":"Caudle","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0046","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1245\/s10434-019-07536-z","article-title":"Lobular histology does not predict the need for axillary dissection among ACOSOG Z0011-eligible breast cancers","volume":"26","author":"Mamtani","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0047","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/s12885-019-5823-x","article-title":"Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases","volume":"19","author":"Majid","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0048","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12282-018-0852-x","article-title":"Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma","volume":"25","author":"Adachi","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0049","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.21037\/atm-21-5169","article-title":"Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001)","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","article-title":"Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis","volume":"184","author":"Gao","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0051","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10549-020-05565-x","article-title":"Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers","volume":"180","author":"Corona","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0052","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/ejso.2002.1423","article-title":"Is invasive lobular carcinoma different from invasive ductal carcinoma?","volume":"29","author":"Mersin","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/B:BREA.0000021038.97593.8b","article-title":"A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast","volume":"85","author":"Korhonen","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0054","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.breast.2004.03.004","article-title":"Infiltrating lobular carcinoma\u2013a comparison of diagnosis, management and outcome with infiltrating duct carcinoma","volume":"13","author":"Molland","year":"2004","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2022.06.016_bib0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjsurg.2006.06.020","article-title":"Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma","volume":"192","author":"Vo","year":"2006","journal-title":"Am J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0056","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1524-4741.2007.00468.x","article-title":"Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?","volume":"13","author":"Jayasinghe","year":"2007","journal-title":"Breast J"},{"key":"10.1053\/j.semdp.2022.06.016_bib0057","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.clbc.2016.03.007","article-title":"Sentinel lymph node biopsy and isolated tumor cells in invasive lobular versus ductal breast cancer","volume":"16","author":"Truin","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0058","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1245\/s10434-008-0153-2","article-title":"Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients","volume":"15","author":"Mittendorf","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0059","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","article-title":"Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000103072.34708.e3","article-title":"Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast","volume":"239","author":"Creager","year":"2004","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0061","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(98)11104-2","article-title":"Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International breast cancer study group","volume":"354","author":"Cote","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2022.06.016_bib0062","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jcp.2005.029991","article-title":"The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma","volume":"59","author":"Cserni","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0063","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ejso.2016.02.259","article-title":"Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis","volume":"42","author":"Nottegar","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0064","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/000313481408001004","article-title":"Extranodal extension on sentinel lymph node dissection: why should we treat it differently?","volume":"80","author":"Choi","year":"2014","journal-title":"Am Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.SLA.0000064361.12265.9A","article-title":"Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden","volume":"237","author":"Stitzenberg","year":"2003","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0066","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1075-122X.2004.21446.x","article-title":"Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery","volume":"10","author":"Changsri","year":"2004","journal-title":"Breast J"},{"key":"10.1053\/j.semdp.2022.06.016_bib0067","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1245\/s10434-014-3752-0","article-title":"The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer","volume":"21","author":"Gooch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0068","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamasurg.2015.1687","article-title":"Size of extranodal extension on sentinel lymph node dissection in the American college of surgeons oncology group Z0011 trial era","volume":"150","author":"Choi","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0069","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","article-title":"Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients","volume":"27","author":"Barrio","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/his.12853","article-title":"Sentinel lymph nodes for breast carcinoma: an update on current practice","volume":"68","author":"Maguire","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2022.06.016_bib0071","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1038\/s41598-021-88716-4","article-title":"Prognostic value of extranodal extension in axillary lymph node-positive breast cancer","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1053\/j.semdp.2022.06.016_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171853","article-title":"Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer","volume":"12","author":"Aziz","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2022.06.016_bib0073","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0b013e31815b446b","article-title":"Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years","volume":"247","author":"Intra","year":"2008","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0074","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0075","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0076","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0077","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0078","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","article-title":"Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes","volume":"22","author":"Plecha","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0079","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-021-06118-6","article-title":"Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review","volume":"186","author":"Man","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0081","first-page":"13","article-title":"The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis","author":"Swarnkar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semdp.2022.06.016_bib0082","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clbc.2021.06.003","article-title":"Regional nodal irradiation for clinically node-positive breast cancer patients with pathologic negative nodes after neoadjuvant chemotherapy","volume":"22","author":"Schlafstein","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0083","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1245\/s10434-021-10830-4","article-title":"Is axillary radiation not inferior to axillary dissection for sentinel lymph node-positive breast cancer after neoadjuvant chemotherapy?","volume":"29","author":"Khan","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0084","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1245\/ASO.2003.03.081","article-title":"Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome","volume":"10","author":"Newman","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0086","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9610(98)00253-0","article-title":"Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer","volume":"176","author":"Kuerer","year":"1998","journal-title":"Am J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0087","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archsurg.1989.01410010027005","article-title":"The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer","volume":"124","author":"McCready","year":"1989","journal-title":"Arch Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0088","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0089","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1245\/ASO.2006.03.010","article-title":"Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic","volume":"13","author":"Klauber-DeMore","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0090","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","article-title":"Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer","volume":"26","author":"Wong","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0091","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0092","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","article-title":"Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases","volume":"163","author":"van Nijnatten","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0093","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0094","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/modpathol.2015.74","article-title":"Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group","volume":"28","author":"Provenzano","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0095","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.24173","article-title":"Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer","volume":"115","author":"Loya","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0096","unstructured":"The American Society of Breast Surgeons. Consensus guideline on axillary management for patients with in-situ and invasive breast cancer: a concise overview. https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-the-Management-of-the-Axilla-Concise-Overview.pdf. Published 2019. Accessed April 26, 2022."},{"key":"10.1053\/j.semdp.2022.06.016_bib0097","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American college of surgeons oncology group (ACOSOG) Z0011: impact on surgeon practice patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0098","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amjsurg.2014.07.001","article-title":"Measuring the impact of the American college of surgeons oncology group Z0011 trial on breast cancer surgery in a community health system","volume":"209","author":"Wright","year":"2015","journal-title":"Am J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0099","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ajcp\/aqw078","article-title":"Sentinel lymph node frozen-section utilization declines after publication of American college of surgeons oncology group Z0011 trial results with no change in subsequent surgery for axillary lymph node dissection","volume":"146","author":"Jorns","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5858\/arpa.2015-0296-OA","article-title":"Decline in frozen section diagnosis for axillary sentinel lymph nodes as a result of the American college of surgeons oncology group Z0011 trial","volume":"140","author":"Bishop","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0101","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.clbc.2017.10.007","article-title":"Expanding implementation of ACOSOG Z0011 in surgeon practice","volume":"18","author":"Weiss","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0102","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1200\/JCO.19.02891","article-title":"Regional nodal management in patients with clinically node-negative breast cancer undergoing upfront surgery","volume":"38","author":"Mittendorf","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0103","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1245\/s10434-021-10726-3","article-title":"Optimizing axillary management in clinical T1-2N0 mastectomy patients with positive sentinel lymph nodes","volume":"29","author":"Kantor","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-019-05243-7","article-title":"Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes","volume":"176","author":"Weiss","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cncr.25606","article-title":"Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience","volume":"117","author":"Liu","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0106","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12282-012-0431-5","article-title":"Reliability of frozen section in breast sentinel lymph node examination","volume":"21","author":"Barakat","year":"2014","journal-title":"Breast Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0107","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amjsurg.2010.01.017","article-title":"Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer","volume":"199","author":"Jensen","year":"2010","journal-title":"Am J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0108","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/PAS.0000000000001311","article-title":"Accuracy of intraoperative frozen section of sentinel lymph nodes after neoadjuvant chemotherapy for breast carcinoma","volume":"43","author":"Grabenstetter","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0109","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5858\/arpa.2020-0411-OA","article-title":"Breast sentinel lymph node frozen section practice: an enterprise audit as a guide for moving forward","volume":"145","author":"Czaja","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2022.06.016_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/tbj.12829","article-title":"Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer","volume":"24","author":"Akay","year":"2018","journal-title":"Breast J"},{"key":"10.1053\/j.semdp.2022.06.016_bib0111","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1245\/ASO.2004.12.005","article-title":"Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty?","volume":"11","author":"Fortunato","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0960-9776(03)00124-3","article-title":"False-negative frozen section of sentinel lymph node biopsy for breast cancer","volume":"13","author":"Holck","year":"2004","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2022.06.016_bib0113","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcp\/112.5.627","article-title":"Intraoperative examination of the sentinel lymph node for breast carcinoma staging","volume":"112","author":"Turner","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0114","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jclinpath-2014-202799","article-title":"False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: a retrospective analysis of patients in a single Asian institution","volume":"68","author":"Wong","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.surge.2017.11.003","article-title":"Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials","volume":"16","author":"Lombardi","year":"2018","journal-title":"Surgeon"},{"key":"10.1053\/j.semdp.2022.06.016_bib0116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-014-3161-x","article-title":"Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases","volume":"148","author":"Poling","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2022.06.016_bib0117","first-page":"e16146","article-title":"Impact of histological type and grade on the diagnostic accuracy of intraoperative frozen section for detecting breast cancer metastasis to axillary sentinel lymph nodes","volume":"13","author":"Hashmi","year":"2021","journal-title":"Cureus"},{"key":"10.1053\/j.semdp.2022.06.016_bib0118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jso.10296","article-title":"The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer","volume":"84","author":"Leidenius","year":"2003","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0119","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/bjs.5139","article-title":"Meta-analysis of sentinel node imprint cytology in breast cancer","volume":"92","author":"Tew","year":"2005","journal-title":"Br J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00129039-200303000-00008","article-title":"Rapid immunohistochemistry for cytokeratin in the intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma","volume":"11","author":"Beach","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0121","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.24182","article-title":"A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer","volume":"115","author":"Krishnamurthy","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0122","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1158\/1078-0432.CCR-06-2512","article-title":"One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients","volume":"13","author":"Tsujimoto","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2022.06.016_bib0123","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/bjs.9386","article-title":"Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer","volume":"101","author":"Tiernan","year":"2014","journal-title":"Br J Surg"},{"key":"10.1053\/j.semdp.2022.06.016_bib0124","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(197701)39:1<164::AID-CNCR2820390127>3.0.CO;2-T","article-title":"Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance","volume":"39","author":"Ridolfi","year":"1977","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.016_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.path.2017.09.004","article-title":"Axillary lymph node inclusions","volume":"11","author":"Cimino-Mathews","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1053\/j.semdp.2022.06.016_bib0126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2559.1988.tb02029.x","article-title":"Benign axillary epithelial lymph node inclusions\u2013a histological pitfall","volume":"13","author":"Holdsworth","year":"1988","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2022.06.016_bib0127","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/PAS.0b013e3181e5e03e","article-title":"Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma","volume":"34","author":"Corben","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0128","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2005.04.7076","article-title":"Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma","volume":"24","author":"Bleiweiss","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0129","first-page":"929","article-title":"Deep learning-based assessment of tumor-associated stroma for diagnosing breast cancer in histopathology images","volume":"2017","author":"Bejnordi","year":"2017","journal-title":"Proc IEEE Int Symp Biomed Imaging"},{"key":"10.1053\/j.semdp.2022.06.016_bib0130","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/his.13305","article-title":"Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer","volume":"71","author":"Holten-Rossing","year":"2017","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2022.06.016_bib0131","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sola","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2022.06.016_bib0132","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257022000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257022000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:24:32Z","timestamp":1760037872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257022000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":132,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0740257022000545"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2022.06.016","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on sentinel node pathology in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2022.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}